BDBM516560 US11053243, Example 105::tert-butyl{(1R)-2-[(2S)-2-{[2-(4- {2-[(2S)-1-acetylpyrrolidin-2- yl]-1H-imidazol-5-yl}phenyl)- 1H-indol-5-yl]carbamoyl} pyrrolidin-1-yl]-2-oxo-1- phenylethyl}carbamate

SMILES CC(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3cc4cc(NC(=O)[C@@H]5CCCN5C(=O)[C@H](NC(=O)OC(C)(C)C)c5ccccc5)ccc4[nH]3)cc2)[nH]1

InChI Key InChIKey=GEHTWTDUDROARO-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 516560   

TargetGenome polyprotein(HCV)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 516560BDBM516560(US11053243, Example 105 | tert-butyl{(1R)-2-[(2S)-...)
Affinity DataEC50:  0.0800nMAssay Description:Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent